Having a good day with a couple of the other larger biotechs. Most of the small biotechs still stuck in Phase 1 and II clinical trials not moving today. Market appears to have punished some of these biotechs in the past 6 months and hopefully when the funds move back in, they'll support the likes of CST and PXS.
- Forums
- ASX - By Stock
- CST
- running nicely